Johnson & Johnson to Participate in the Leerink Global Biopharma Conference

Rhea-AI Summary

Johnson & Johnson (JNJ) to participate in Leerink Global Biopharma Conference with Joe Wolk, EVP, CFO representing the company. The live webcast will be available on their website for investors.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12^th, at the Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240212450230/en/

Media contact:

media-relations@its.jnj.com

Investor contact:

investor-relations@its.jnj.com

Source: Johnson & Johnson

FAQ

When is Johnson & Johnson (JNJ) participating in the Leerink Global Biopharma Conference?

Johnson & Johnson (JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th.

Who will represent Johnson & Johnson (JNJ) at the conference?

Joe Wolk, Executive Vice President, Chief Financial Officer, will represent Johnson & Johnson (JNJ) at the conference.

Where will the conference take place?

The conference will take place at the Fontainebleau Miami Beach, FL.

How can investors access the live webcast?

Investors can access the live webcast by visiting the Johnson & Johnson website at www.investor.jnj.com.

When will the audio webcast replay be available?

The audio webcast replay will be available approximately 48 hours after the webcast.